Literatur
Bolten WW, Lang B, Wagner AV et al (1999) Consequences and costs of NSAID-gastropathy in Germany. Akt Rheumatol 24:127–134
Bolten WW, Kruger K, Reiter-Niesert S et al (2016) DGRh recommendations for the implementation of current security aspects in the NSAID treatment of musculoskeletal pain. Z Rheumatol 75:103–116
Bombardier C, Laine L, Reicin A et al (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343:1520–1528
Catella-Lawson F, Reilly MP, Kapoor SC et al (2001) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345:1809–1817
Conaghan PG (2012) A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int 32:1491–1502
Coxib and Traditional Nsaid Trialists’ (Cnt) Collaboration (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 382:769–779
Douthwaite AH, Lintott GAM (1938) Gastroscopic observation of the effect of aspirin and certain other substances on the stomach. Lancet 2:1222–1225
Gomm W, Von Holt K, Thome F et al (2016) Association of proton pump inhibitors with risk of dementia: A pharmacoepidemiological claims data analysis. JAMA Neurol 73:410–416
Lindhardsen J, Gislason GH, Jacobsen S et al (2014) Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study. Ann Rheum Dis 73:1515–1521
Mitchell JA, Warner TD (1999) Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol 128:1121–1132
Poddubnyy D, Rudwaleit M, Haibel H et al (2012) Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 71:1616–1622
Roubille C, Richer V, Starnino T et al (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 74:480–489
Silverstein FE, Graham DY, Senior JR et al (1995) Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 123:241–249
Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232–235
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
W.W. Bolten und K. Krüger geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Additional information
Redaktion
U. Müller-Ladner, Bad Nauheim
H.-M. Lorenz, Heidelberg
M. Schneider, Düsseldorf
Rights and permissions
About this article
Cite this article
Bolten, W.W., Krüger, K. Coxibe. Z Rheumatol 75, 595–598 (2016). https://doi.org/10.1007/s00393-016-0148-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-016-0148-5